Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Clinica Baviera significantly increases revenue and market share in the first half of 2025

Clinica Baviera achieved revenue growth of 18% to €154.7 million in the first half of 2025 and increased its market share by 32%. While the company continued its expansion in Europe, particularly in the United Kingdom, Spain remained its most important market, accounting for 67% of total revenue. Despite higher operating costs and investments, net profit fell by 5%, mainly due to initial investments in the United Kingdom. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Clinica Baviera has already paid €1.57 in dividends. The last payout was in June.

Financials

In the last quarter, Clinica Baviera had revenue of €82.96m and net profit of €11.51m

(EUR)	June 2026	YoY
Revenue	82.96m	11.32%
Gross profit	82.96m	11.32%
Net profit	11.51m	15.78%
EBITDA	25.49m	23.42%

Fundamentals

Metric	Value
Market capitalization	€862.53m
Number of shares	16.03m
52-week high/low	€62.00 - €40.10
Dividend yield	2.95%
Dividends TTM	€1.57
Beta	0.75
P/E ratio	19.28
PEG ratio	1.44
P/B ratio	7.72
P/S ratio	2.72

Company profile

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.

Name	Clinica Baviera
CEO	Eduardo Baviera Sabater
Headquarters	Madrid, ma Spain
Website	clinicabaviera.com
Sector	Health Care
Industry	Health Care Providers & Services
IPO	03/04/2007
Employees	2,009